Abby Silber has diverse experience supporting life sciences company strategy. She has over 8 years experience in life sciences consulting, with the vast majority of that time focused on supporting clients to understand and communicate product value. As a member of the Evidence Strategy team, her expertise is in setting the strategy for evaluations of product value, assessing key gaps, designing evidence generation studies and communicating evidence. Her work has spanned diverse therapeutic areas and markets across neuropsychiatry, GI, immunology, medical device and technology, hematology and oncology, including work on cell and gene therapy.

Abby’s work typically involves tapping into data, whether collected via primary research, secondary literature or real-world databases, with thoughtful study design to ensure the data source is optimized for the business objectives. Her robust methodological expertise lends itself to protocol design, study execution, value communication, scientific dissemination and training. Abby’s commercial strategy experience and background have supported successful product launches and evaluations, access optimization, establishing share of voice, supporting LOE and competitive landscape changes.

Prior to joining Trinity, Abby started her career at IQVIA. She has an MPH and BA from Boston University.